Paila, Yamuna D.
Pajon, Rolando
Banbury, Barbara
Fields, Paul
Maglinao, Maha
De Rosa, Stephen C.
Morris, Daryl
McElrath, M. Juliana
Siangphoe, Uma
Cohen, Kristen W.
Paris, Robert
Funding for this research was provided by:
Moderna, Inc. (N/A)
Moderna, Inc. (N/A)
Moderna, Inc. (N/A)
Moderna, Inc. (N/A)
Moderna, Inc. (N/A)
Moderna, Inc. (N/A)
Moderna, Inc. (N/A)
Moderna, Inc. (N/A)
Moderna, Inc. (N/A)
Moderna, Inc. (N/A)
Moderna, Inc. (N/A)
Article History
Received: 9 September 2025
Accepted: 5 February 2026
First Online: 19 February 2026
Competing interests
: R.Paj, M.M., K.C., U.S., and R.Par are employees of Moderna, Inc., and hold stock/stock options in the company. B.B. and P.F. are employees and shareholders in Adaptive Biotechnologies, Seattle, WA. Y.D.P. is a former employee of Moderna Inc. MJM has an institutional collaborative research agreement with Moderna, Inc., which has no effect on the planning, conduct or interpretation of the work presented in this manuscript. The other authors do not have a competing interest.